Herriot Tabuteau, Chief Executive Officer, 10% Owner at Axsome Therapeutics, Inc. (AXSM), sold 49,664 shares at $212.01 ($10.5M) on 2026-08-05, disclosed to the SEC on 2026-08-07.
Scheduled sale ($10.5M) by Chief Executive Officer, 10% Owner under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $212.01 | 45,004 | $9.5M | 90.5% |
| 2 | $213.95 | 4,660 | $997K | 9.5% |
| Total | $212.19 avg | 49,664 | $10.5M | 100% |
| Filing → |
| AXSM | SELL | 2026-02-02 | $6.0M | — | Filing → |
| AXSM | SELL | 2026-01-07 | $23.9M | — | Filing → |
| AXSM | SELL | 2025-12-04 | $23.3M | — | Filing → |